Thrombin-induced platelet microbicidal protein (PMP) is considered to play an important role in preventing streptococcal endocarditis. However, the structural features and functions of PMPs have not been well characterized, and their antibacterial spectra against other common endocarditis pathogens, such as the staphylococci, are not known. Thrombin stimulation of washed rabbit platelets (108/ml) yielded a PMP-rich preparation with a specific activity of -25 U/mg of protein as determined by Bacilus subtilis bioassay.
Bacterial-platelet (PLT) interactions represent a critical first step in the induction of infective endocarditis (IE [9, 10] ). The ability of an organism to induce IE appears to involve both an ability to adhere to and aggregate PLTs on the one hand (10, 21) and evasion of the antibacterial capacity of PLTs on the other hand (4) . Although PLTs may occasionally internalize bacteria via phagocytosis, intracellular killing does not occur (4) ; rather, the primary mechanism of PLT antibacterial host defense is generally considered to involve a-granule-derived bactericidal proteins (5, 6) .
During generalized clotting, rabbit and human PLTs release bactericidal substances which possess activity predominantly against gram-positive organisms (6, 14, 23) . Similarly, following specific exposure to thrombin, a release of a-granule-derived PLT microbicidal protein(s) (PMPs) with bactericidal activity against classical IE pathogens such as viridans streptococci has been documented (5) . These findings have led to the notion that organisms intrinsically resistant to PMP(s) would manifest a selective survival advantage during PLT-bacteria interactions at the cardiac vegetation surface. Such thrombin-induced antibacterial proteins have also been contamination. The PLT-rich plasma fraction was collected into citrated, siliconized tubes and centrifuged for 10 min at 2,000 x g to pellet the PLTs. The resulting PLT 20 min, 37°C [5] ). Following this thrombin-induced PLT a-granule secretion, residual PLT material was removed by centrifugation (2,000 x g, 10 min), and the PMP-rich supematant was recovered.
PMP preparations were stored at -20°C and used for subsequent studies within 30 days.
Determination of PMP bactericidal activity. The total protein content of PMP preparations was determined spectrophotometrically (18) , and the PMP bactericidal activity was determined by techniques modified from those of Donaldson and Tew (6) . Briefly, bioactivity assays were performed with Bacillus subtilis (ATCC 6633), an indicator organism highly sensitive to the bactericidal action of PLT-derived PMP (5 Partial PMP purification by anionic membrane filtration. Leukocyte-derived bactericidal defensins are cationic and purifiable by anionic affinity techniques (6, 12, 22) . We thus attempted to partially purify PMPs from thrombin-induced PLT preparations, exploiting their suspected cationic nature, via anionic membrane filtration. Cellulose acetate (CA; 0.22 ,um; Costar, Cambridge, Mass.), CA/nitrate (CAJN; 0.45 ,um; Millipore Corp., Bedford, Mass.), polysulfonate (0.45 ,um; Gelman Sciences, Ann Arbor, Mich.), and asbestos (Seitz Clarifying Hercules C5-L3; Republic Filter, Milldale, Conn.) membranes were used in parallel studies. Aliquots (1 to 10 ml) of thrombin-induced PMP preparations or bioactive column-separated PMP fractions were filtered through siliconized syringe-mounted membranes, and the filtrate was collected. The membranes were washed twice with PBS and then eluted with 2 ml of 1.5 M NaCl-TN buffer (pH 7.2). The filtrates and eluates were then assayed for residual anti-B. subtilis bioactivity as previously described; 1.5 M NaCl-TN buffer alone identically filtered through membranes was used as a control in the bioactivity assays.
Partial characterization of PMP by anionic resin absorption. Anionic resin adsorption was used to further investigate the charge characteristics of thrombin-induced PMP preparations. Cellulose phosphate (CP), CA, and SPS resins (all obtained from Sigma Chemical Co.) were used in an effort to bind ionically the bioactive PMP moiety. Thrombin-induced PMP preparations and column-separated bioactive PMP fractions were exposed to CP, CA, or SPS resin at a ratio of 2 U of PMP to 1 mg of resin. PMP-resin suspensions were tumbled for 5 min and centrifuged for 10 min at 10,000 x g, and supernatants were collected and tested for residual anti-B. subtilis bioactivity. The pellets containing PMP-resin admixtures were then washed twice with PBS and subjected to various eluting solutions, including 1.5 M NaCl (pH 7.2), 10 ,000 x g; the supernatants were collected and tested for postadsorption anti-B. subtilis bioactivity; the postadsorption supernatants were also subjected to SDS-PAGE. Nonadsorbed PMP samples served as controls in both the bioactivity assays and SDS-PAGE analyses. LYS exclusion. To exclude the possibility that LYS, itself a bactericidal protein present within PLTs, was acting as a contaminating bioactive molecule in PMP preparations, we compared the heat stabilities, anti-B. subtilis and anti-M. luteus bactericidal activities, and SDS-PAGE protein profiles of PMP preparations with those of commercial LYS alone. Egg-white LYS (Sign a Chemical Co.) was used as a control, representative of PLT LYS, since the two are very similar in MW, specificity, and heat stability (6, 23) . Eggwhite LYS (ranging from 1 to 10 ,ug/ml [511 to 5,110 U/ml]), dissolved in either 0.066 M potassium phosphate buffer (pH 6.25) or CP resin-inactivated PMP supernatants, as well as thrombin-induced PMP preparations and bioactive columnseparated PMP fractions (100 U/ml), was heated to 50 or 80°C, each for 15 or 30 min. CP resin-inactive PMP preparation supernatants were used as a LYS diluent to control for the possibility that LYS heat inactivation would be reduced in the presence of PMP preparation protein concentrations. After cooling, the heat-treated LYS and PMP samples were immediately assayed for residual bioactivity versus B. subtilis and M. luteus by the microtiter well assay described above; non-heat-treated LYS and bioactive PMP samples served as controls.
Comparative agar diffusion bioassays of LYS and PMP preparations were also performed. Wells (5 mm) were cut into brain heart infusion agar plates (15 by 100 mm), which were then confluently inoculated with 1-ml suspensions of either 108 B. subtilis or M. luteus cells per ml. Fifty microliters of either egg-white LYS (0.1 to 10 ,ug/ml in either 0.066 M potassium phosphate buffer or CP resin-inactivated PMP supernatants) or PMP (concentration range = 100 to 200 U/ml) was placed into the wells. The plates were then incubated for 24 (Fig. 2) . There was a conspicuous trend between clinical source of the S. aureus isolate and PMP resistance. Isolates recovered from patients with endocarditis were more frequently PMP resistant than nonendocarditis isolates; however, this difference did not achieve statistical 2 . Distribution of S. aureus isolate PMP susceptibility. S. aureus isolates were exposed to 100 U of thrombin-induced PMP per ml at inocula of 103/ml (37°C); percent survival was calculated following 2 h of PMP exposure. A PMP susceptibility breakpoint was arbitrarily established as .40% survival following 2 h of exposure to PMP under the conditions described above. Each datum point represents the mean of at least three independent assays with c5% standard deviation (error bars removed for clarification). S. aureus (-103/ml) was exposed to 100 U of thrombin-induced PMP per ml (37°C). Percent survival and optical density were determined as described in the legend to Fig. 2 . Data represent three independent experiments (error bars represent standard deviation).
significance (P = 0.27). At an inoculum of 103 CFU/ml, staphylococcal survival ranged from a low of 6.5% ± 2.5% for the most PMP-susceptible strain to a high of 90.6% + 2.1% for the most PMP-resistant strain. Brief sonication and microscopic examination of PMP-exposed S. aureus samples confirmed that the reductions in CFU per milliliter were not due to organism aggregation. Based on the PMP susceptibility breakpoint of .40% survival of the original inoculum (103 CFU/ml) at 2 h, -67% of S. aureus isolates tested were considered PMP'. Similar heterogeneous susceptibility to the action of PMP was seen at higher S. aureus inocula, although the actual percent survival for each respective isolate increased with inoculum size. Each isolate exhibited time-dependent PMP susceptibility, with maximum PMPinduced killing achieved at 2 h (Fig. 3) . In contrast to the rapid lysis of B. subtilis, PMP-induced lysis of S. aureus isolates was prolonged, occurring over the 2-h period monitored. However, similar to results with B. subtilis, reduction in viability of S. aureus (CFU per milliliter) consistently preceded a decrease in sample optical density, suggesting that PMP-induced S. aureus bacteriolysis occurred subsequent to cell death (Fig. 3) .
Partial purification of thrombin-induced PMP by column chromatography. Sephadex G-50 column elution fractions 39 to 63 (elution volumes 78 to 126 ml) were found to contain the predominant protein peak (Fig. 4) , accounting for -90% of protein in the original thrombin-induced PMP preparation sample. Of importance, the vast majority of anti-B. subtilis and anti-S. aureus PMP bioactivities were also localized within fractions 39 to 63, correlating with an estimated molecular mass of -20 to 35 kDa and indicating that PMP was stable under the conditions of chromatography. Such column elution fractions contained a mean PMP bioactivity of 40 U/ml (mean specific activity of -32 U/mg of protein). A minor protein peak, possessing anti-B. subtilis bioactivity, was also identified (Fig. 4) Partial purification of PMP by anionic membrane filtration. CA/N and asbestos anionic membrane filters quantitatively removed the anti-B. subtilis bioactivity from thrombin-induced PMP preparations, suggesting that the bioactive moiety of PMP is cationic. Near-complete bioactivity was then recoverable by 1.5 M NaCl elution of CA/N or asbestos anionic membranes following exposure to PMP, suggesting that adsorption of PMP occurred via reversible ionic interactions (Table 1) . NaCl elution buffer alone, passed over membrane materials, exhibited no bioactivity. Dialysis (cutoff, 3.5 kDa) of anionic membrane eluates against several volumes of PBS to remove the eluting NaCl buffer failed to further enhance the eluate's bioactivity. On SDS-PAGE, the low-MW protein, seen in bioactive PMP preparations, was absent from filtrates recovered from CA/N and asbestos filters (Table 1) ; SDS-PAGE revealed the presence of this same low-MW protein band in bioactive eluates from CA/N and asbestos membranes (Fig. 5) . In no case were such low-MW protein bands found within PBS elution samples of PMP-exposed anionic membranes.
Partial characterization of PMP by anionic resin adsorption. Following adsorption of PMP preparations by CP or SPS (but not CA) resins, all residual bioactivity was removed ( Table 2 ). Of note, despite the complete elimination Although several elution buffers were tested (including 1.5 M NaCl), no bioactivity could be recovered from PMPexposed CP and SPS resins, suggesting that PMP(s) was retained by these resins under the elution conditions tested ( Table 2 ). LYS exclusion. Thrombin-induced PMP and column-separated bioactive PMP preparations were tested for the presence of LYS, to exclude the possibility that LYS was contaminating these preparations and contributing to the observed antibacterial bioactivity. By agar diffusion assay, B. subtilis was very sensitive to both thrombin-induced PMP and column-separated PMP preparations (zone size = 15 mm), while no zone of growth inhibition was observed for M. luteus around wells containing such PMP preparations.
In contrast, zone sizes of 4 to 7 mm were detected around wells containing 0.1 to 10 ,g of LYS per ml, respectively, using LYSS M. luteus as the indicator organism; there were no detectable zones of inhibition surrounding wells containing PMP preparations with M. luteus as the indicator organism.
Thrombin-induced PMP preparations, as well as bioactive fractions from column chromatography, retained full bioactivity after heating to 80°C for 15 min. In contrast, LYS (10 ,g/ml), diluted in buffer alone or in CP resin-inactivated PMP supernatant (to normalize total protein concentration with that of bioactive PMP preparations), significantly lost anti-M. luteus activity when exposed for 15 min to temperatures of .60'C; such samples heated to 80°C for 15 min exhibited a near-complete loss of anti-M. luteus bioactivity. SDS-PAGE comparisons of the bioactive PMP preparations with purified LYS distinguished the characteristic low-MW protein band (8,500) from the larger LYS band (-14,300; Fig. 5 ) in reduced gels. Moreover, SDS-PAGE demonstrated that anionic membrane filtration, anionic resin adsorption, and B. subtilis adsorption each failed to remove the LYS protein band (14 to 15 kDa), while concomitantly removing both anti-B. subtilis bioactivity as well as the low-MW protein band from such preparations.
DISCUSSION
The induction of IE is a multistep process in which the interaction of bacteria and PLTs at the cardiac valve surface is felt to be a crucial event. PLTs appear to play both protagonistic and antagonistic roles in initiation of IE, particularly in the presence of endothelium-derived tissue factor (7) . From a protagonistic perspective, the adherence of bacteria to PLTs at the surface of damaged valvular endothelium serves as a first step for localized PLT aggregation and eventual vegetation development (9, 20) . The subsequent elaboration of tissue factor from either the bacteriacolonized endothelium or subendothelial stroma further propagates the valvular infection by inducing localized procoagulant activity (2, 7, 8) . In addition, tissue factor stimulates PLTs to release thrombospondin, a potent enhancer of bacterial adherence to activated PLTs and PLT-fibrin matrices (13) .
In support of PLT-mediated bacterial antagonism, recent investigations have shown that tissue factor and thrombin both stimulate rabbit PLT a-granules to release low-MW bactericidal proteins (5) that we have termed PMPs. Human PLTs have also been demonstrated to secrete analogous PMP-like molecules with bioactivities equivalent to that of rabbit PMP (5) . Both rabbit and human PMPs exhibit potent antibacterial activity against the viridans streptococci, the most common endocarditis pathogens; moreover, rabbit PMP is suspected of inhibiting the development of streptococcal endocarditis in vivo (5) . The present study was designed to determine the basic characteristics of PMP, as well as to define the in vitro bioactivity of PMP against S. aureus, the most common intravascular pathogen (19) . Rabbit PLTs were used in this study for several reasons: (i) similarities of rabbit and human PLT-derived PMP (5); (ii) availability of rabbits as dedicated PLT donors; and (iii) future use of the well-established rabbit model (1, 10, 11) to further characterize the in vivo role of PMP in IE.
The current investigation demonstrated that there was considerable heterogeneity among S. aureus strains in PMPinduced killing, with one-third of the strains found to be PMP resistant. This finding suggests that resistance to PMP is an important virulence determinant in the survival of valveadherent staphylococci. Also, following exposure to PMP, staphylococcal killing consistently preceded decreases in optical density, suggesting that the mechanism of PMP bactericidal activity primarily involves cell membrane effects leading to cell death, with subsequent cell lysis. Compared with that of B. subtilis, both PMP-induced killing and lysis of S. aureus were less rapid and complete. The reduction in B. subtilis or S. aureus CFU per milliliter as a result of PMP exposure was not due to PMP-induced organism aggregation, since ultrasonication strategies prevented bacterial clumping, as confirmed microscopically, without altering cell viability.
Gel filtration chromatography, used to partially purify PMP from thrombin-stimulated PLT Collectively, these data provide compelling evidence which virtually excludes LYS as a contaminating, bioactive molecule present in thrombin-induced PMP preparations.
We recently studied the ability of S. aureus cells to adhere to and aggregate PLTs in vitro (24) . These studies showed that among the same 28 S. aureus isolates tested in the present study, there was a highly significant positive correlation between the ability of a staphylococcal strain to adhere to PLTs and that strain's capacity to induce PLT aggregation. In contrast, there was no correlation between staphylococcal susceptibility to the bactericidal activity of PMPs and either PLT adherence or aggregation; this discrepancy suggested that adherence to and aggregation of PLTs by S. aureus are covirulence factors, while PMP resistance may be an independent virulence factor of S. aureus. Moreover, we observed a clear trend for S. aureus isolates which caused IE strains to be more frequently PMP resistant than those strains isolated from non-IE cases. The lack of a statistically significant relationship between PMP resistance on the one hand and the propensity of clinical strains to cause IE on the other hand may indicate that PMP acts in conjunction with other host defense factors to modulate IE. Future evaluation of the mechanism(s) of PMP antibacterial action and the role of PMP in modulating IE await the further purification and characterization of the PMP(s). These investigations are ongoing in our laboratory.
